First Trust Advisors Portfolio holdings
AUM
$124B
This Quarter Return
+3.03%
1 Year Return
+23.24%
3 Year Return
+77.03%
5 Year Return
+144.93%
10 Year Return
+396.84%
AUM
$53B
AUM Growth
+$53B
(+5.4%)
Cap. Flow
+$1.6B
Cap. Flow
% of AUM
3.02%
Top 10 Holdings %
Top 10 Hldgs %
12.11%
Holding
2,575
New
173
Increased
1,092
Reduced
1,144
Closed
163
Top Buys
| 1 |
First Trust Utilities AlphaDEX Fund
FXU
|
$583M |
| 2 |
Lumen
LUMN
|
$160M |
| 3 |
Exact Sciences
EXAS
|
$125M |
| 4 |
Sarepta Therapeutics
SRPT
|
$118M |
| 5 |
Arista Networks
ANET
|
$103M |
Top Sells
| 1 |
First Trust Health Care AlphaDEX Fund
FXH
|
$511M |
| 2 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
$152M |
| 3 |
Open Text
OTEX
|
$105M |
| 4 |
Equinix
EQIX
|
$96.1M |
| 5 |
Pfizer
PFE
|
$92.4M |
Sector Composition
| 1 | Technology | 25.2% |
| 2 | Healthcare | 12.51% |
| 3 | Communication Services | 10.72% |
| 4 | Financials | 10.66% |
| 5 | Consumer Discretionary | 8.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FBZ
101
DELISTED
First Trust Brazil AlphaDEX Fund
FBZ
| $113M | 0.21% | 7,163,217 -704,355 | -9% | -$11.1M |
|
102
Acadia Pharmaceuticals
ACAD
$4.38B
| $113M | 0.21% | 4,219,069 -596,707 | -12% | -$16M |
|
|
SPLK
103
DELISTED
Splunk Inc
SPLK
| $112M | 0.21% | 890,373 +157,153 | +21% | +$19.8M |
|
|
104
Pfizer
PFE
$141B
| $111M | 0.21% | 2,560,566 -2,134,011 | -45% | -$92.4M |
|
105
First Trust Switzerland AlphaDEX Fund
FSZ
$82.9M
| $110M | 0.21% | 2,146,010 -211,021 | -9% | -$10.8M |
|
106
Gen Digital
GEN
$18.6B
| $109M | 0.21% | 5,020,188 -1,307,514 | -21% | -$28.5M |
|
107
Regeneron Pharmaceuticals
REGN
$61.5B
| $109M | 0.2% | 346,960 -13,602 | -4% | -$4.26M |
|
108
Ionis Pharmaceuticals
IONS
$6.8B
| $109M | 0.2% | 1,688,275 -903,564 | -35% | -$58.1M |
|
109
Eli Lilly
LLY
$657B
| $108M | 0.2% | 975,350 +226,281 | +30% | +$25.1M |
|
110
Neurocrine Biosciences
NBIX
$13.8B
| $108M | 0.2% | 1,277,700 +194,643 | +18% | +$16.4M |
|
|
BLUE
111
DELISTED
bluebird bio
BLUE
| $107M | 0.2% | 842,121 +78,813 | +10% | +$10M |
|
112
Grifois
GRFS
$6.78B
| $107M | 0.2% | 5,073,910 -51,809 | -1% | -$1.09M |
|
113
BioMarin Pharmaceuticals
BMRN
$11.2B
| $107M | 0.2% | 1,249,061 -12,847 | -1% | -$1.1M |
|
114
Nektar Therapeutics
NKTR
$568M
| $107M | 0.2% | 3,005,999 +856,819 | +40% | +$30.5M |
|
115
Southern Company
SO
$102B
| $106M | 0.2% | 1,920,115 +367,221 | +24% | +$20.3M |
|
|
BICK
116
DELISTED
First Trust BICK Index Fund
BICK
| $106M | 0.2% | 3,926,094 -386,082 | -9% | -$10.4M |
|
117
Omnicom Group
OMC
$15.2B
| $104M | 0.2% | 1,271,586 +31,965 | +3% | +$2.62M |
|
118
Exelon
EXC
$44.1B
| $104M | 0.2% | 2,173,317 +1,092,170 | +101% | +$52.4M |
|
119
First Trust Developed Markets ex-US AlphaDEX Fund
FDT
$597M
| $104M | 0.2% | 1,925,656 -188,384 | -9% | -$10.2M |
|
120
Autodesk
ADSK
$67.3B
| $103M | 0.19% | 631,398 -47,406 | -7% | -$7.72M |
|
121
Thermo Fisher Scientific
TMO
$186B
| $102M | 0.19% | 348,903 -81,326 | -19% | -$23.9M |
|
122
Procter & Gamble
PG
$368B
| $101M | 0.19% | 923,772 -597,315 | -39% | -$65.5M |
|
123
Check Point Software Technologies
CHKP
$20.7B
| $101M | 0.19% | 872,515 -147,461 | -14% | -$17M |
|
124
Qiagen
QGEN
$10.1B
| $101M | 0.19% | 2,484,585 -200,555 | -7% | -$8.13M |
|
125
First Trust Germany AlphaDEX Fund
FGM
$71.6M
| $101M | 0.19% | 2,406,303 -236,576 | -9% | -$9.9M |
|